Atópiás dermatitisz (ekcéma): vizsgálatok itt: Egyesült Államok
76 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleDigital Mindfulness Meditation in Adolescents With Atopic Dermatitis
- Where
- New York
- Életkor
- 13 év to 17 év
- People
- 40
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT07746427 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Auburn Hills, Boca Raton, Boise, Bowling Green, Clifton, Fountain Valley, Lafayette, Los Angeles, Macon, New York, Normal, North Little Rock, Oklahoma City, Omaha, Owensboro, Phoenix, St. Petersburg, Tampa, Wilmington
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07690371 · EU 2025-524925-42-00 - 2. fázisTaking peopleTreatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
- Where
- New York
- Életkor
- 12 év and over
- People
- 56
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07242638 - No phaseTaking peopleA Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
- Where
- Bethesda
- Életkor
- 3 év to 100 év
- People
- 10 000
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06732414 - 4. fázisNot yet taking people in Egyesült ÁllamokAD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes
- Where
- City of Saint Peters, Crest Hill, Fairfax, Grand Rapids, Greensburg, Houston, Libertyville, Mobile, Vienna, Virginia Beach
- Életkor
- 12 év and over
- People
- 250
- Run by
- Forefront Dermatology S.C
See details and how to joinNCT07856134 - 1. fázisTaking peopleA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- Where
- Irvine, New York, The Bronx
- Életkor
- 18 év to 72 év
- People
- 237 worldwide
- Run by
- Bambusa Therapeutics
See details and how to joinNCT06808477 · EU 2025-522918-23-00 - 2. fázisTaking peoplePlatform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Where
- Arlington, Atlanta, Birmingham, Brighton, Brooklyn, Cypress, Dallas, Fort Smith, Fountain Valley, Houston, Los Angeles, Louisville, Macon, Miami, Portsmouth, Sacramento, Saint Joseph, San Antonio, Santa Ana, Santa Monica, St. Petersburg, Troy, Washington D.C.
- Életkor
- 18 év to 100 év
- People
- 224 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06947993 · EU 2024-519081-49-00 - 2. fázisTaking peopleStudy of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Arlington, Atlanta, Auburn Hills, Bay City, Beverly Hills, Birmingham, Camp Hill, Canton, Chicago, Clarksville, Clinton Township, Fort Lauderdale, Fremont, Hot Springs, Houston, Las Vegas, Louisville, Mayfield Heights, Miami, Miramar, New Albany, New York, Norfolk, San Antonio, San Diego, Santa Monica, Warren, West Hills, West Lafayette, Wilmington
- Életkor
- 18 év to 75 év
- People
- 105
- Run by
- Enveda Therapeutics
See details and how to joinNCT07298395 - 4. fázisTaking peopleThe Impact of Dietary Salt on the Severity of Eczema
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 40
- Run by
- University of California, San Francisco
See details and how to joinNCT07447063 - No phaseNot yet taking people in Egyesült ÁllamokAn Observational Study of Patients With Dermatologic Disease
- Where
- New York
- People
- 2 000 000
- Run by
- Target PharmaSolutions, Inc.
See details and how to joinNCT07748169 - 4. fázisTaking peopleThe Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
- Where
- San Francisco
- Életkor
- 18 év and over
- People
- 50
- Run by
- University of California, San Francisco
See details and how to joinNCT07487831 - 3. fázisTaking peopleA Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Birmingham, Columbus, Kirksville, Las Vegas, Lee's Summit, Metairie, Oxnard, Palmdale, Robbinsville, Sacramento, Savannah, Tamarac, The Bronx
- Életkor
- 12 év and over
- People
- 510 worldwide
- Run by
- Nektar Therapeutics
See details and how to joinNCT07711418 · EU 2025-525129-11-00 - 2/3. fázisTaking peopleA Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)
- Where
- Irving
- Életkor
- 18 év to 80 év
- People
- 190
- Run by
- Turn Therapeutics
See details and how to joinNCT07355075 - 4. fázisNot yet taking people in Egyesült ÁllamokOpzelura Experience Study
- Where
- Winston-Salem
- Életkor
- 2 év and over
- People
- 50
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07661979 - 2. fázisTaking peopleA Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Birmingham, Bryant, Camp Hill, Cape Coral, Clarksville, Clifton, Columbus, Fargo, Hollywood, Huntington Beach, Indianapolis, Los Angeles, Meridian, Miami, New York, North Lauderdale, North Miami Beach, Northridge, Pasadena, Phoenix, Pittsburgh, Reno, Sacramento, San Antonio, Savannah, Skokie, Tampa, Tarzana, Wheat Ridge
- Életkor
- 18 év to 65 év
- People
- 280 worldwide
- Run by
- Apollo Therapeutics Ltd
See details and how to joinNCT07599813 - 2. fázisTaking peopleFood-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
- Where
- Bethesda
- Életkor
- 3 év to 21 év
- People
- 200
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT03835767 - No phaseTaking peopleCorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
- Where
- Waltham
- Életkor
- 18 év and over
- People
- 10 000
- Run by
- CorEvitas
See details and how to joinNCT04504955 - No phaseTaking peoplePPDTM CorEvitasTM Chronic Hand Eczema (CHE) Drug Safety and Effectiveness Registry
- Where
- Waltham
- Életkor
- 18 év and over
- People
- 2000
- Run by
- CorEvitas
See details and how to joinNCT07598058 - No phaseTaking peopleReal World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
- Where
- San Diego
- Életkor
- 12 év and over
- People
- 150
- Run by
- Pfizer
See details and how to joinNCT06899204 - 2. fázisTaking peoplePharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic Dermatitis
- Where
- San Antonio
- Életkor
- 6 hónap to 23 hónap
- People
- 35 worldwide
- Run by
- Galderma R&D
See details and how to joinNCT07660835 · EU 2025-525027-27-00 - 4. fázisTaking peopleObtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
- Where
- Sacramento
- Életkor
- 12 év and over
- People
- 40
- Run by
- Integrative Skin Science and Research
See details and how to joinNCT07560618 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Anderson, Burien, Charlotte, Columbus, Fargo, Kew Gardens, Lancaster, Los Angeles, Mayfield Heights, New York, Ocala, Portland, Rolling Meadows, Southlake, Tampa, Woodbury
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00 - 2. fázisTaking peopleA Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Boca Raton, Dallas, Encinitas, Indianapolis, Los Angeles, Northridge, Plainfield, San Antonio, Sugar Land
- Életkor
- 18 év and over
- People
- 200
- Run by
- Enveda Therapeutics
See details and how to joinNCT07643766 - No phaseTaking peopleTopical Treatment for Atopic Dermatitis
- Where
- Winston-Salem
- Életkor
- 9 év and over
- People
- 30
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06244212 - 2. fázisCsak meghívásosLong-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Anderson, Burien, Charlotte, Columbus, Fargo, Kew Gardens, Lancaster, Los Angeles, Mayfield Heights, New York, Ocala, Portland, Rolling Meadows, Southlake, Tampa, Woodbury
- Életkor
- 18 év to 75 év
- People
- 400 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07734415